Cargando…

A combination screening to identify enhancers of para-aminosalicylic acid against Mycobacterium tuberculosis

Para-aminosalicylic acid (PAS) is an antibiotic that was largely used for the multi-therapy of tuberculosis in the twentieth century. To try to overcome the inconvenience of its low efficacy and poor tolerance, we searched for novel chemical entities able to synergize with PAS using a combination sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heo, Jinyeong, Koh, Dahae, Woo, Minjeong, Kwon, Doyoon, de Almeida Falcão, Virgínia Carla, Wood, Connor, Lee, Honggun, Kim, Kideok, Choi, Inhee, Jang, Jichan, Brodin, Priscille, Shum, David, Delorme, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980009/ https://www.ncbi.nlm.nih.gov/pubmed/35379873 http://dx.doi.org/10.1038/s41598-022-08209-w

Ejemplares similares

Mycobacterium tuberculosis Infection and Innate Responses in a New Model of Lung Alveolar Macrophages
por: Woo, Minjeong, et al.
Publicado: (2018)

PlateEditor: A web-based application for the management of multi-well plate layouts and associated data
por: Delorme, Vincent, et al.
Publicado: (2021)

para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
por: Zheng, Jun, et al.
Publicado: (2013)

Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screening
por: Benítez, Diego, et al.
Publicado: (2022)

Analysis of mutations leading to para-aminosalicylic acid resistance in Mycobacterium tuberculosis
por: Pandey, Bharati, et al.
Publicado: (2019)

The Balance of Apoptotic and Necrotic Cell Death in Mycobacterium tuberculosis Infected Macrophages Is Not Dependent on Bacterial Virulence
por: Butler, Rachel E., et al.
Publicado: (2012)

Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis
por: Zhang, Tingting, et al.
Publicado: (2019)

Para-Aminosalicylic Acid: Pas
Publicado: (1950)

Repurposing Eltrombopag for Multidrug Resistant Staphylococcus aureus Infections
por: Lee, Hyunjung, et al.
Publicado: (2021)

Para-Aminosalicylic Acid in Pulmonary Tuberculosis
por: Horne, Norman W.
Publicado: (1949)

Molecular characterization of para-aminosalicylic acid resistant Mycobacterium tuberculosis clinical isolates in southwestern China
por: Luo, Ming, et al.
Publicado: (2019)

Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to para-Aminosalicylic Acid in Mycobacterium tuberculosis
por: Yu, Ji-fang, et al.
Publicado: (2022)

Methionine Antagonizes para-Aminosalicylic Acid Activity via Affecting Folate Precursor Biosynthesis in Mycobacterium tuberculosis
por: Howe, Michael D., et al.
Publicado: (2018)

dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains
por: Moradigaravand, Danesh, et al.
Publicado: (2016)

A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters
por: Nikiforov, Petar O., et al.
Publicado: (2016)

Proteomics of Mycobacterium Infection: Moving towards a Better Understanding of Pathogen-Driven Immunomodulation
por: Hoffmann, Eik, et al.
Publicado: (2018)

Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease
por: Cechetto, Jonathan, et al.
Publicado: (2011)

p-Aminosalicylic Acid (P.A.S.)
por: Spring, F. S.
Publicado: (1949)

Aminosalicylates and COVID-19: Facts or Coincidences?
por: Magro, Fernando, et al.
Publicado: (2021)

Clinical Study of the Use of Para-Aminosalicylic Acid in the Treatment of Pulmonary Tuberculosis
por: Donaldson, Rose I. L.
Publicado: (1949)

Self-Assembling Polymers with p-Aminosalicylate Anions Supported by Encapsulation of p-Aminosalicylate for the Improvement of Drug Content and Release Efficiency
por: Keihankhadiv, Shadi, et al.
Publicado: (2023)

Development and Evaluation: A Behavioral Activation Mobile Application for Self-Management of Stress for College Students
por: Na, Hyunjoo, et al.
Publicado: (2022)

Identification of radiation‐induced EndMT inhibitors through cell‐based phenomic screening
por: Song, Yeonhwa, et al.
Publicado: (2018)

Inhibitors of Na(+)/K(+) ATPase exhibit antitumor effects on multicellular tumor spheroids of hepatocellular carcinoma
por: Song, Yeonhwa, et al.
Publicado: (2020)

Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays
por: Nikiforov, Petar O., et al.
Publicado: (2017)

STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection
por: Queval, Christophe J., et al.
Publicado: (2016)

Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo
por: Simeone, Roxane, et al.
Publicado: (2015)

Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hosts
por: Orgeur, Mickael, et al.
Publicado: (2021)

Five-Aminosalicylic Acid: An Update for the Reappraisal of an Old Drug
por: Perrotta, Cristiana, et al.
Publicado: (2015)

Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

Cyanidin-3-Glucoside Suppresses Cytokine-Induced Inflammatory Response in Human Intestinal Cells: Comparison with 5-Aminosalicylic Acid
por: Serra, Diana, et al.
Publicado: (2013)

Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains
por: Wei, Wenjing, et al.
Publicado: (2019)

Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations
por: Wang, Wei, et al.
Publicado: (2022)

Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus
por: Quang, Nguyen Thanh, et al.
Publicado: (2021)

Endometrial Tuberculosis Treated with Para-Aminosalicylic Acid (PAS): Report of a Case with Subsequent Pregnancy
por: Kullander, Stig
Publicado: (1952)

Drug Discovery Platform Targeting M. tuberculosis with Human Embryonic Stem Cell-Derived Macrophages
por: Han, Hyo-Won, et al.
Publicado: (2019)

P-aminosalicylate metabolism in cancer patients sensitive and resistant to chemotherapy.
por: Lavigne, J. G., et al.
Publicado: (1977)

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
por: Bich Hanh, Bui Thi, et al.
Publicado: (2021)

Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling
por: Queval, Christophe J., et al.
Publicado: (2017)

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
por: Freeman, Hugh James
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ka6139nmarr3fuhju2j8hooh04